It is an honor to collaborate with excellent advocates, clinicians and scientists on an ongoing project to develop long-term, bi-directional relationships with early career researchers, and what we learned.

www.nature.com/articles/s41...

Our manuscript highlighting the design, goals, and experiences of the MBCRC Advocate Researcher Program (MARP), which focused on building meaningful, bidirectional partnerships between advocates and researchers was published in npj breast. www.nature.com/articles/s41...

Advocates! Friends’ advocate focused virtual event that provides a deeper dive into our discussions from last week's diagnostics meeting is February 19!

Register today and share your questions - we'd love to answer them during the event!

friendsofcancerresearch.org/event/advanc...

That CREW! 😍

Check out @focr.bsky.social poster at #SABCS24 presented by Brittany McKelvey (P2-02-18) at 5:30 CT today! The poster includes findings from the #DigitalPATH Project focused on aligning AI digital pathology tools that measure HER2. Learn more here: friendsofcancerresearch.org/digital-path...

I’m so glad that BlueSky became a thing before #SABCS24 - sad to miss the conference in person (I’ll make it one day!) but so glad I have a reliable place to stay up to date on the SCIENCE.

Thank you to the >60 people who attended our webinar today! Missed out? You can watch it on the @focr.bsky.social YouTube channel now! www.youtube.com/live/gGa4eAg...

Starting now! Join us!

So excited for @focr.bsky.social advocate focused event this Thursday to discuss findings from our Annual Meeting! Register today! friendsofcancerresearch.org/event/friend...

Looking forward to the @focr.bsky.social Annual Meeting Recap event for advocates on December 5! Register today! friendsofcancerresearch.org/event/friend...

Our final panel focuses on how we can integrate ctDNA into prospective clinical trials to support intermediate endpoint validation. #FriendsAM24

Our final panel focuses on how we can integrate ctDNA into prospective clinical trials to support intermediate endpoint validation. #FriendsAM24

Our lunch keynote is between Friends’ CEO Jeff Allen and NCI Director Kimryn Rathmell. #FriendsAM24

Panel 2 is discussing approaches to including prismatic elements in post market studies. #FriendsAM24

The first panel focuses on approaches to interpreting interim overall survival. #FriendsAM24

“In times of change and chaos, there is lots of opportunity.” -Dr. Califf on his thoughts about the election last week. #FriendsAM24

Excited my first round of posts here are about the Friends of Cancer Research Annual Meeting! Our CEO Jeff Allen kicked off the meeting and now we’re into an opening keynote with Dr. Rob Califf. #FriendsAM24